{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:55:49Z","timestamp":1790985349535,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuro.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T16:57:07Z","timestamp":1732899427000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Acyclovir provides protection against 6-OHDA-induced neurotoxicity in SH-SY5Y cells through the kynurenine pathway"],"prefix":"10.1016","volume":"106","author":[{"given":"Selma","family":"Sezen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Karadayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Yesilyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Burul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Gulsahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozkaraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Okkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medine","family":"Gulluce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuro.2024.11.005_bib1","first-page":"874","article-title":"Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity","volume":"30","author":"Al-Alawi","year":"2022","journal-title":"SPJ"},{"issue":"2","key":"10.1016\/j.neuro.2024.11.005_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.61845\/agrimedical.1471854","article-title":"Experimental models in Parkinson\u2019s disease: advantages and disadvantages","volume":"2","author":"Altunlu","year":"2024","journal-title":"A\u011fR. \u0131 Med J."},{"key":"10.1016\/j.neuro.2024.11.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105376","article-title":"The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies","volume":"158","author":"Amin","year":"2022","journal-title":"Neurochem. Int."},{"issue":"18","key":"10.1016\/j.neuro.2024.11.005_bib4","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.neuro.2024.11.005_bib5","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.3390\/ijms22136737","article-title":"The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications","volume":"22","author":"Behl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.neuro.2024.11.005_bib6","first-page":"1277","article-title":"Tackling Parkinson's Disease as a Global Challenge","volume":"13","author":"Bhidayasiri","year":"2023","journal-title":"J. Park. Dis."},{"issue":"6","key":"10.1016\/j.neuro.2024.11.005_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41419-020-2626-6","article-title":"TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity","volume":"11","author":"Br\u00e1s","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.neuro.2024.11.005_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2-3","key":"10.1016\/j.neuro.2024.11.005_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000512874","article-title":"Herpesvirus Infections and Risk of Parkinson's Disease","volume":"20","author":"Camacho-Soto","year":"2020","journal-title":"Neurodegener. Dis."},{"issue":"9","key":"10.1016\/j.neuro.2024.11.005_bib10","first-page":"1467","article-title":"L-Methionine Protects against Oxidative Stress and Mitochondrial Dysfunction in an In Vitro Model of Parkinson's Disease","volume":"10","author":"Catanesi","year":"2021","journal-title":"Antioxid. (Basel, Switz. )"},{"issue":"1","key":"10.1016\/j.neuro.2024.11.005_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2225800","article-title":"Research progress on the kynurenine pathway in the prevention and treatment of Parkinson's disease","volume":"38","author":"Chen","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuro.2024.11.005_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.566922","article-title":"Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases","volume":"12","author":"Chen","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.neuro.2024.11.005_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S1092852919001664","article-title":"Risk of Parkinson's disease among patients with herpes zoster: a nationwide longitudinal study","volume":"25","author":"Cheng","year":"2020","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.neuro.2024.11.005_bib14","first-page":"453","article-title":"Antioxidant Therapeutics in Parkinson's Disease: Current Challenges and Opportunities","volume":"10","author":"Duarte-Jurado","year":"2021","journal-title":"Antioxid. (Basel, Switz. )"},{"issue":"12","key":"10.1016\/j.neuro.2024.11.005_bib15","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1007\/s11033-021-06779-y","article-title":"Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson's disease","volume":"48","author":"Ferah Okkay","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.neuro.2024.11.005_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","article-title":"The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A","volume":"19","author":"Fu","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.neuro.2024.11.005_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11064-018-2688-3","article-title":"Striatal Protection in nNOS Knock-Out Mice After Quinolinic Acid-Induced Oxidative Damage","volume":"44","author":"Ger\u00f3nimo-Olvera","year":"2019","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuro.2024.11.005_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13880209.2012.716852","article-title":"Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells","volume":"51","author":"Guo","year":"2013","journal-title":"Pharm. Biol."},{"issue":"6","key":"10.1016\/j.neuro.2024.11.005_bib19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00213-020-05503-1","article-title":"The combination of acyclovir and dexamethasone protects against Alzheimer's disease-related cognitive impairments in mice","volume":"237","author":"Hui","year":"2020","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.neuro.2024.11.005_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psychres.2016.11.017","article-title":"Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity","volume":"247","author":"Kegel","year":"2017","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.neuro.2024.11.005_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s11064-024-04105-z","article-title":"MM165- A Small Hybrid Molecule Modulates the Kynurenine Pathway and Attenuates Lipopolysaccharide-Induced Memory Deficits and Inflammation","volume":"49","author":"Kota\u0144ska","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2024.11.005_bib22","doi-asserted-by":"crossref","DOI":"10.2174\/0118715303273145240110100341","article-title":"Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alzheimer's Disease in Rats","author":"Kumar","year":"2024","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"7","key":"10.1016\/j.neuro.2024.11.005_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006075","article-title":"Herpes zoster correlates with increased risk of Parkinson's disease in older people: A population-based cohort study in Taiwan","volume":"96","author":"Lai","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.neuro.2024.11.005_bib24","article-title":"Amauroderma rugosum Protects PC12 Cells against 6-OHDA-Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuro.2024.11.005_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuro.2024.11.005_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4335272","article-title":"M1 Microglia Induced Neuronal Injury on Ischemic Stroke via Mitochondrial Crosstalk between Microglia and Neurons","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuro.2024.11.005_bib27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuro.2024.11.005_bib28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.neuro.2024.11.005_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep13888","article-title":"Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease","volume":"5","author":"Luan","year":"2015","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.neuro.2024.11.005_bib30","doi-asserted-by":"crossref","first-page":"29835","DOI":"10.18632\/oncotarget.8104","article-title":"Emerging preclinical pharmacological targets for Parkinson's disease","volume":"7","author":"More","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.neuro.2024.11.005_bib31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1211\/0022357056442","article-title":"Aciclovir protects against quinolinic-acid-induced oxidative neurotoxicity","volume":"57","author":"M\u00fcller","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuro.2024.11.005_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12974-018-1374-3","article-title":"IL-17A contributes to perioperative neurocognitive disorders through blood-brain barrier disruption in aged mice","volume":"15","author":"Ni","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neuro.2024.11.005_bib33","unstructured":"Phase 1- NCT03282916, Anti-viral Therapy in Alzheimer's Disease, 2018-2024. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03282916, (accessed 29 May 2024). Note:This is part of a clinical trial report included in the literature."},{"key":"10.1016\/j.neuro.2024.11.005_bib34","unstructured":"Phase 1- NCT03056495, Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease, 2017-2024. (VostatAD01), https:\/\/clinicaltrials.gov\/study\/NCT03056495?cond=alzheimer&intr=vorinostat&rank=1 (accessed 29 May 2024). Note:This is part of a clinical trial report included in the literature."},{"key":"10.1016\/j.neuro.2024.11.005_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.794770","article-title":"Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment","volume":"12","author":"Que","year":"2021","journal-title":"Front. Immunol."},{"issue":"Pt B","key":"10.1016\/j.neuro.2024.11.005_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuro.2024.11.005_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-024-03751-y","article-title":"Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson's disease models","volume":"15","author":"Rodr\u00edguez-P\u00e9rez","year":"2024","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.neuro.2024.11.005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152686","article-title":"Protection of 6-OHDA neurotoxicity by PGF2\u03b1 through FP-ERK-Nrf2 signaling in SH-SY5Y cells","volume":"450","author":"Sano","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2024.11.005_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2018.04.034","article-title":"Sustained Activation of JNK Induced by Quinolinic Acid Alters the BDNF\/TrkB Axis in the Rat Striatum","volume":"383","author":"Santana-Mart\u00ednez","year":"2018","journal-title":"Neurosci"},{"issue":"1","key":"10.1016\/j.neuro.2024.11.005_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/molecules23010191","article-title":"Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection","volume":"23","author":"Sas","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.neuro.2024.11.005_bib41","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/brainsci13060852","article-title":"Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer's Disease and Geriatric Depression","volume":"13","author":"Savonije","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuro.2024.11.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115322","article-title":"Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives","volume":"206","author":"Schalkwijk","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"55","key":"10.1016\/j.neuro.2024.11.005_bib43","doi-asserted-by":"crossref","first-page":"117609","DOI":"10.1007\/s11356-023-30417-8","article-title":"Assessment of antimicrobial activity and In Vitro wound healing potential of ZnO nanoparticles synthesized with Capparis spinosa extract","volume":"30","author":"Sezen","year":"2023","journal-title":"Environ. Sci. Pollut. Res. Int"},{"issue":"3","key":"10.1016\/j.neuro.2024.11.005_bib44","first-page":"1220","article-title":"The in-vitro Wound Healing Potential of Essential Oil Extracted from Mentha longifolia L","volume":"27","author":"Sezen","year":"2023","journal-title":"J. Res. Pharm."},{"issue":"4","key":"10.1016\/j.neuro.2024.11.005_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.47582\/jompac.1198326","article-title":"Neuroprotective effect of methanol extract of Capparis spinosa L. fruits in an in-vitro experimental model of Parkinson\u2019s disease","volume":"3","author":"Sezen","year":"2022","journal-title":"J. Med. Palliat. Care."},{"issue":"2","key":"10.1016\/j.neuro.2024.11.005_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13318-021-00733-w","article-title":"Acyclovir Brain Disposition: Interactions with P-gp, Bcrp, Mrp2, and Oat3 at the Blood-Brain Barrier","volume":"47","author":"Shan","year":"2022","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.neuro.2024.11.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153678","article-title":"Bisphenol A induced neuronal apoptosis and enhanced autophagy in vitro through Nrf2\/HO-1 and Akt\/mTOR pathways","volume":"500","author":"Shen","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2024.11.005_bib48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuro.2021.03.009","article-title":"IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's disease","volume":"84","author":"Sodhi","year":"2021","journal-title":"Neurotoxicology"},{"issue":"20","key":"10.1016\/j.neuro.2024.11.005_bib49","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jmb.2018.08.002","article-title":"Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed \u03b1-Synuclein Aggregation","volume":"430","author":"Tavassoly","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.neuro.2024.11.005_bib50","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/fcp.12817","article-title":"Effects of mangiferin and its combination with nNOS inhibitor 7-nitro-indazole (7-NI) in 6-hydroxydopamine (6-OHDA) lesioned Parkinson's disease rats","volume":"36","author":"Tiwari","year":"2022","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuro.2024.11.005_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/cells9020314","article-title":"Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease","volume":"9","author":"Vall\u00e9e","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.neuro.2024.11.005_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/biology9050103","article-title":"Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms","volume":"9","author":"V\u00e1radi","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.neuro.2024.11.005_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2020.100270","article-title":"Kynurenine pathway in Parkinson's disease-An update","volume":"21","author":"Venkatesan","year":"2020","journal-title":"eNeurologicalSci"},{"issue":"1","key":"10.1016\/j.neuro.2024.11.005_bib54","article-title":"VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease","volume":"8","author":"Weidung","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuro.2024.11.005_bib55","unstructured":"WHO. Parkinson disease. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease\u3009 (accessed 29 May 2024)."},{"issue":"4","key":"10.1016\/j.neuro.2024.11.005_bib56","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11064-018-2494-y","article-title":"Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K\/Akt\/GSK-3\u03b2\/CREB Signaling Pathway","volume":"43","author":"Wu","year":"2018","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuro.2024.11.005_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmedgenet-2017-105047","article-title":"Genetics of Parkinson's disease and related disorders","volume":"55","author":"Zhang","year":"2018","journal-title":"J. Med. Genet."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X24001372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X24001372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T22:20:38Z","timestamp":1736461238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X24001372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":57,"alternative-id":["S0161813X24001372"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2024.11.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acyclovir provides protection against 6-OHDA-induced neurotoxicity in SH-SY5Y cells through the kynurenine pathway","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}